Hanover Portfolio Acquisitions (HVPA) Changes Name to Endonovo Therapeutics
Hanover Portfolio Acquisitions has announced that, effective immediately, it will now operate under the name Endonovo Therapeutics. As part of this change, the company’s website, www.hanoverpai.com, has officially been changed to www.endonovo.com. The company’s email addresses will soon migrate to an @endonovo.com suffix. The adoption of the name Endonovo Therapeutics coincides with the company’s development of noninvasive, time-varying electromagnetic field (TVEMF) therapies for inflammatory, autoimmune, and degenerative diseases, including diabetes, liver disease, and cardiovascular disease. Endonovo Therapeutics’ technology has the capability to mobilize and expand stem cells 80-fold to therapeutic levels, as well as up-regulate hundreds of components involved in…